CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator

Nature Immunology
Guifang CaiGordon J Freeman

Abstract

CD160, a glycosylphosphatidylinositol-anchored member of the immunoglobulin superfamily, is expressed on both cytolytic lymphocytes and some unstimulated CD4+ T cells. Here we show that CD160 expression was increased after activation of human CD4+ T cells and that crosslinking CD160 with monoclonal antibody strongly inhibited CD3- and CD28-mediated activation. We found that herpesvirus entry mediator (HVEM) was a ligand of CD160 that acted as a 'bidirectional switch' for T cell activation, producing a positive or negative outcome depending on the engagement of HVEM by CD160 and known HVEM ligands such as B and T lymphocyte attenuator (BTLA) and the T lymphocyte receptor LIGHT. Inhibition of CD4+ T cell activation by HVEM-transfected cells was dependent on CD160 and BTLA; when the cysteine-rich domain 1 of HVEM was deleted, this inhibition was lost, resulting in strong T cell activation. CD160 thus serves as a negative regulator of CD4+ T cell activation through its interaction with HVEM.

References

May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·B Seed, A Aruffo
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·A BensussanE Carosella
Feb 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·K TamadaL Chen
Feb 13, 2001·Molecular Immunology·M R SarriasJ D Lambris
Feb 14, 2002·Trends in Biochemical Sciences·Jean-Luc BodmerJürg Tschopp
Jul 18, 2002·Immunity·Kenneth A FrauwirthCraig B Thompson
Dec 6, 2002·The American Journal of Pathology·Ryan M GillJoan S Hunt
Dec 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Philippe Le BouteillerArmand Bensussan
Jun 6, 2003·Cytokine & Growth Factor Reviews·Steve W Granger, Sandra Rickert
Jun 11, 2003·Nature Immunology·Norihiko WatanabeKenneth M Murphy
Oct 21, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aliz BarakonyiPhilippe Le Bouteiller
Jan 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Lino C GonzalezDan L Eaton
Feb 8, 2005·The Journal of Clinical Investigation·Yang WangYang-Xin Fu
Sep 1, 2005·Proceedings of the National Academy of Sciences of the United States of America·Timothy C CheungCarl F Ware
Sep 20, 2005·The Journal of Biological Chemistry·Deanne M CompaanSarah G Hymowitz
Sep 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Motoi MaedaFumio Takei
Aug 26, 2006·Nature Reviews. Immunology·Kenneth M MurphyJohn R Sedý
Jan 16, 2007·The Journal of Investigative Dermatology·Sofia AbecassisArmand Bensussan

❮ Previous
Next ❯

Citations

Aug 21, 2012·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Marie-Laure ThibultDaniel Olive
Aug 31, 2011·Cancer Immunology, Immunotherapy : CII·Jang-June ParkKoji Tamada
Jul 23, 2011·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Waka IshidaAtsuki Fukushima
May 19, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Marcio O LasaroHildegund Cj Ertl
Jan 22, 2008·Nature Immunology·Jonathan Kaye
Oct 25, 2008·Nature Reviews. Immunology·John R SedýCarl F Ware
Apr 1, 2009·Proceedings of the National Academy of Sciences of the United States of America·Timothy C CheungCarl F Ware
Jun 4, 2008·The Journal of Experimental Medicine·Marcos W SteinbergMitchell Kronenberg
Apr 10, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Shahram Salek-Ardakani, Michael Croft
Oct 18, 2011·Current Opinion in HIV and AIDS·Donatella Ciuffreda, Arthur Y Kim
Mar 24, 2010·Annual Review of Immunology·Theresa L Murphy, Kenneth M Murphy
Dec 30, 2009·The Journal of Clinical Investigation·Laurent DerréDaniel E Speiser
Mar 22, 2013·Retrovirology·Marie LarssonAdeeba Kamarulzaman
May 3, 2011·PloS One·Corinne SchaerNicola L Harris
Nov 10, 2013·PloS One·Rachel FlynnShahram Salek-Ardakani
Dec 7, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Julia E RagerRebecca C Fry
Oct 29, 2013·In Vitro Cellular & Developmental Biology. Animal·Yoshiaki AndoManabu Inobe
Apr 14, 2012·Journal of Biomedicine & Biotechnology·Daria CapeceEdoardo Alesse
Jun 6, 2009·Seminars in Immunopathology·Marcos W SteinbergMitchell Kronenberg
Feb 27, 2013·Journal of Leukocyte Biology·Douglas V DolfiE John Wherry
Sep 3, 2014·Journal of Translational Medicine·Mohamed El-FarGeorge Kukolj
Dec 17, 2014·Proceedings of the National Academy of Sciences of the United States of America·Tim D HolmesGraham P Cook
Mar 27, 2012·Trends in Immunology·Lukas BaitschDaniel E Speiser
Apr 18, 2015·The Journal of Infectious Diseases·Carolina PomboMichael R Betts
Sep 9, 2015·Frontiers in Immunology·Isabelle Le MercierRandolph J Noelle
Apr 28, 2012·Critical Reviews in Clinical Laboratory Sciences·Alvaro GonzálezEstibaliz Alegre
Aug 1, 2015·Nature Reviews. Drug Discovery·Kathleen M MahoneyGordon J Freeman
Dec 4, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Daisuke HokutoYoshiyuki Nakajima
May 28, 2011·Seminars in Immunology·Nina PilatThomas Wekerle

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.